[Ranking] TOP 17 Proteomics / Biotechnology Companies Q3/2023
Proteomics, a sub-industry of Biotechnology, plays a critical role in the worldwide economy by driving advancements in the understanding and application of proteins. Proteins are the building blocks of life and are involved in every biological process, making proteomics an essential field for various sectors including healthcare, pharmaceuticals, agriculture, and environmental sciences.
The profound influence of proteomics extends beyond its immediate applications. By unraveling the mysteries of proteins, this industry has a ripple effect across diverse sectors. It enables the development of personalized medicine, the improvement of crop yields, the discovery of new biomarkers for diseases, and the advancement of drug discovery and development.
The economic magnitude of the proteomics industry is on an upward trajectory. According to a report by Grand View Research, the global proteomics market is expected to reach a value of $24.8 billion by 2027, driven by the increasing demand for personalized medicine, advancements in mass spectrometry and protein microarrays, and the growing focus on biomarker discovery.
In recent years, proteomics has witnessed notable trends, breakthroughs, and obstacles. The emergence of high-throughput technologies has revolutionized protein analysis, enabling the study of thousands of proteins simultaneously. Breakthroughs in proteomic research have led to the identification of new drug targets, the development of innovative diagnostic tools, and the understanding of complex biological processes. However, challenges such as data analysis and interpretation, standardization of experimental protocols, and the need for robust bioinformatics tools continue to shape the industry.
The proteomics landscape is ever-changing, driven by technological advancements, scientific discoveries, and evolving research priorities. As the industry continues to evolve, it is crucial to explore and recognize the leading companies in proteomics that are driving innovation, pushing boundaries, and shaping the future of biotechnology.
#17 Abcam Plc
Description: Abcam Plc, headquartered in Cambridge, United Kingdom, is a leading company in the Proteomics industry. Founded in 1998, the company has grown to employ approximately 1.6 thousand employees. With a revenue of around 500 million dollars, Abcam specializes in providing high-quality antibodies, proteins, and other reagents to support life science research. Their extensive catalog of over 110,000 products caters to the needs of researchers and scientists worldwide, offering a wide range of tools for proteomics research. Abcam's commitment to quality and innovation has made them a trusted partner in the biotechnology industry, providing essential tools and resources for advancing scientific discovery and improving human health.
#16 Bio-Techne Corporation
Description: Bio-Techne Corporation, headquartered in Minneapolis, United States, is a leading player in the Proteomics industry. Founded in 1976, the company has established itself as a prominent provider of innovative solutions in the field of biotechnology. With a workforce of approximately 3,500 employees, Bio-Techne is committed to advancing the understanding of biological processes and enabling scientific discoveries. The company's revenue stands at an impressive 1.2 billion dollars, reflecting its strong market presence. Bio-Techne's extensive range of products and services in Proteomics caters to the needs of researchers, clinicians, and pharmaceutical companies worldwide. Through its cutting-edge technologies and expertise, Bio-Techne continues to drive advancements in proteomic research, contributing to the development of new therapies and diagnostics.
#15 Qiagen N.V.
Description: Qiagen N.V., headquartered in Venlo, Netherlands, is a leading company in the Proteomics industry. Founded in 1984, Qiagen specializes in developing and providing innovative sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. With approximately 5.2 thousand employees, Qiagen operates globally and offers a wide range of products and solutions for proteomics research. The company's revenue stands at around 1.5 billion US dollars. Qiagen is committed to advancing proteomics through its cutting-edge technologies, including sample preparation, protein extraction, purification, and analysis. With its comprehensive portfolio, Qiagen empowers researchers and scientists worldwide to make significant discoveries and advancements in the field of proteomics.
#14 Sartorius AG
Description: Sartorius AG, headquartered in Göttingen, Germany, is a leading company in the Proteomics industry. Founded in 1870, the company has a rich history and extensive expertise in the biotechnology sector. With approximately 10,000 employees, Sartorius AG is dedicated to providing innovative solutions for proteomic research. The company offers a wide range of products and services, including laboratory instruments, consumables, and software solutions that support the analysis and characterization of proteins. Sartorius AG is committed to advancing proteomic research by delivering high-quality tools and technologies to scientists and researchers worldwide. With a revenue of 1.8 billion dollars, the company has established itself as a key player in the biotechnology industry, driving advancements in proteomics and contributing to scientific discoveries.
#13 Bio-Rad Laboratories, Inc.
Description: Bio-Rad Laboratories, Inc. is a leading biotechnology company operating in the Proteomics industry. Based in Hercules, United States, Bio-Rad specializes in the development, manufacture, and marketing of innovative products and solutions for the life sciences research and clinical diagnostics markets. The company offers a wide range of proteomics technologies, including protein electrophoresis, western blotting, protein quantitation, and protein purification. With a strong presence in the industry since its founding in 1952, Bio-Rad has established itself as a trusted provider of high-quality products and services to researchers and healthcare professionals worldwide. With a workforce of approximately 8,000 employees, the company generates an annual revenue of 2 billion dollars, solidifying its position as a key player in the Proteomics industry.
#12 Bruker Corporation
Description: Bruker Corporation, based in Billerica, United States, is a leading company in the Proteomics industry. Since its establishment in 1960, Bruker has been dedicated to developing and manufacturing scientific instruments for molecular and materials research. With a workforce of approximately 6,000 employees, Bruker operates globally, providing innovative solutions for proteomics research, including mass spectrometers, protein analyzers, and molecular imaging systems. The company's products enable scientists and researchers to study the structure, function, and interactions of proteins, advancing the understanding of diseases, drug discovery, and personalized medicine. Bruker has achieved significant success in the Proteomics industry, generating an estimated revenue of 2.7 billion dollars.
#11 Waters Corporation
Description: Waters Corporation, headquartered in Milford, United States, is a leading player in the Proteomics industry. The company was founded in 1958 and currently employs around 7,000 individuals. With an annual revenue of 2.8 billion dollars, Waters Corporation specializes in providing innovative solutions for proteomics research and analysis. Their cutting-edge technologies and instruments enable scientists to study and understand proteins, their structure, function, and interactions. Waters Corporation's products and services cater to a wide range of applications in the biotechnology field, including drug discovery and development, biomarker research, clinical diagnostics, and personalized medicine. Through their dedication to scientific advancements and collaboration with researchers, Waters Corporation continues to make significant contributions to the proteomics industry.
#10 Charles River Laboratories International, Inc.
Description: Charles River Laboratories International, Inc., headquartered in Wilmington, North America, is a leading company in the Proteomics industry. Established in 1947, the company has grown to employ approximately 18.5 thousand employees globally. With a revenue of around 2.8 billion dollars, Charles River Laboratories International is dedicated to providing essential products and services to help pharmaceutical, biotechnology, and academic researchers expedite their research and drug development efforts. The company's expertise in proteomics allows them to offer a wide range of solutions, including protein characterization, protein identification, protein quantification, and biomarker discovery. Charles River Laboratories International plays a crucial role in advancing scientific discoveries and improving human and animal health through their innovative proteomics technologies and services.
#9 Illumina, Inc.
Description: Illumina, Inc. is a leading biotechnology company headquartered in San Diego, United States. Founded in 1998, Illumina operates in the Proteomics industry. With a workforce of approximately 8,000 employees, the company has established itself as a key player in the field. Illumina specializes in genetic sequencing and array-based solutions for genotyping, gene expression, and epigenetics. The company's innovative technologies have revolutionized the study of genomics, enabling researchers to explore the complexities of the human genome and other organisms. Illumina's cutting-edge products and services have contributed significantly to advancements in personalized medicine, agricultural research, and scientific discovery. With a revenue of around 3 billion dollars, Illumina continues to drive innovation and shape the future of biotechnology.
#8 PerkinElmer, Inc.
Description: PerkinElmer, Inc. is a leading biotechnology company operating in the Proteomics industry. Headquartered in Waltham, United States, the company was founded in 1937. With a workforce of approximately 13,000 employees, PerkinElmer is dedicated to providing innovative solutions in the field of proteomics. The company offers a wide range of products and services for protein analysis and research, including advanced instruments, reagents, consumables, and software. PerkinElmer's proteomics solutions enable scientists and researchers to study the structure, function, and interactions of proteins, leading to advancements in drug development, personalized medicine, and disease research. With a revenue of 3.8 billion dollars, PerkinElmer continues to drive advancements in the proteomics industry through its cutting-edge technologies and commitment to scientific innovation.
#7 Agilent Technologies, Inc.
Description: Agilent Technologies, Inc. is a leading player in the Proteomics industry, operating in the Biotechnology sector. With its headquarters in Santa Clara, United States, Agilent Technologies specializes in providing innovative solutions for proteomics research. The company was founded in 1999 and currently employs approximately 17,000 professionals worldwide. Agilent Technologies has achieved significant success in the industry, generating an annual revenue of 5.2 billion US dollars. Their expertise lies in developing advanced technologies and instruments for protein analysis, enabling researchers to gain valuable insights into the structure and function of proteins. Through their cutting-edge products and solutions, Agilent Technologies continues to drive advancements in proteomics research, supporting scientists and pharmaceutical companies in their quest to develop new therapies and treatments.
#6 Eurofins Scientific SE
Description: Eurofins Scientific SE is a leading company in the field of proteomics within the biotechnology industry. Headquartered in Luxembourg, Europe, Eurofins offers a wide range of proteomic services to help clients in various sectors, including pharmaceuticals, healthcare, and agriculture. With a strong focus on advanced analytics and cutting-edge technologies, Eurofins provides comprehensive solutions for protein analysis, protein identification, and protein characterization. The company's proteomics division plays a vital role in advancing research and development efforts, enabling scientists to gain a deeper understanding of protein structures, functions, and interactions. With a workforce of approximately 50,000 employees and annual revenues of 5.3 billion dollars, Eurofins continues to be a global leader in the proteomics sector, driving innovation and delivering high-quality solutions to its clients.
#5 Merck KGaA
Description: Merck KGaA, headquartered in Darmstadt, Germany, is a leading company operating in the Proteomics industry within the broader field of Biotechnology. Founded in 1668, Merck KGaA has a long-standing history of innovation and scientific excellence. With a workforce of approximately 57,000 employees, the company is committed to advancing proteomics research and development. Merck KGaA offers a wide range of products and solutions that support proteomics research, including antibodies, reagents, and analytical instruments. The company's dedication to providing high-quality products has made it a trusted partner for scientists and researchers around the world. With an annual revenue of 18.4 billion dollars, Merck KGaA continues to drive advancements in proteomics and contribute to the growth of the biotechnology industry.
#4 GE Healthcare
Description: GE Healthcare, headquartered in Chicago, United States, is a leading player in the Proteomics industry. The company was founded in 1994 and currently employs approximately 54,000 individuals worldwide. With a revenue of 19.8 billion US dollars, GE Healthcare offers innovative solutions and technologies in the field of biotechnology. They provide a wide range of products and services, including advanced proteomic research tools, diagnostic imaging systems, and healthcare software. GE Healthcare's focus on proteomics enables scientists and researchers to better understand complex biological processes, leading to advancements in personalized medicine and drug discovery. With their strong presence and extensive expertise, GE Healthcare continues to drive innovation and contribute to the growth of the biotechnology industry.
#3 Danaher Corporation
Description: The Danaher Corporation, headquartered in Washington, D.C., is a leading global player in the Proteomics industry. Founded in 1969, the company has grown to employ approximately 80,000 individuals worldwide. With annual revenues reaching 22 billion dollars, Danaher operates a diverse portfolio of businesses within the biotechnology sector. Leveraging their expertise in proteomics, Danaher develops and manufactures cutting-edge technologies and instruments for protein analysis, enabling researchers and scientists to gain insights into the structure, function, and interactions of proteins. Through their innovative solutions, Danaher aims to accelerate advancements in biotechnology and contribute to the development of novel therapies, diagnostics, and personalized medicine.
#2 Thermo Fisher Scientific Inc.
Description: Thermo Fisher Scientific Inc. is a leading company in the Proteomics industry. Headquartered in Waltham, United States, the company was founded in 1956. With a workforce of approximately 75,000 employees, Thermo Fisher Scientific operates globally, providing innovative solutions in biotechnology. The company's revenue stands at an impressive 36 billion dollars. Thermo Fisher Scientific is known for its extensive range of products and services in proteomics, offering cutting-edge technologies and instruments for protein analysis and characterization. Their solutions cater to various research areas, including drug discovery, biomarker identification, and personalized medicine. Thermo Fisher Scientific's commitment to advancing proteomics research has solidified its position as a key player in the biotechnology industry.
#1 F. Hoffmann-La Roche Ltd
Description: F. Hoffmann-La Roche Ltd, headquartered in Basel, Switzerland, is a leading player in the Proteomics industry. Established in 1896, Roche has a rich history of innovation and research in the biotechnology sector. With a workforce of around 97,000 employees, Roche has a global presence and a strong focus on developing solutions in proteomics. The company's proteomics endeavors involve the study of proteins and their functions, aiming to uncover valuable insights into disease mechanisms and potential therapeutic targets. Roche's commitment to advancing proteomics research is evident through its collaborations with academic institutions and biotech partners, as well as its investments in cutting-edge technologies. With a revenue of 58.3 billion dollars, Roche continues to drive advancements in proteomics, contributing to the development of personalized medicine and improving patient outcomes.
Proteomics, a sub-industry of Biotechnology, has seen significant growth in recent years, with several companies emerging as industry leaders. These companies have made significant contributions to the field and have been recognized for their achievements.
One unexpected finding in the analysis is the diversity of companies within the Proteomics sub-industry. While some focus on developing cutting-edge technologies for protein analysis, others specialize in providing proteomic services to researchers and pharmaceutical companies.
Among the top companies in the Proteomics sub-industry is Company A, known for its innovative proteomic platforms and solutions. The company has received numerous awards for its groundbreaking research and has established collaborations with leading academic institutions.
The success of these top companies can be attributed to their strong focus on research and development. They invest heavily in developing advanced technologies and methodologies for protein analysis, allowing researchers to gain deeper insights into complex biological systems.
What sets these eminent companies apart from their industry rivals is their ability to integrate proteomics with other disciplines such as genomics, metabolomics, and bioinformatics. This interdisciplinary approach enables a more comprehensive understanding of biological processes and has the potential to drive breakthrough discoveries.